---
title: "Alibaba Health Declares Final Dividend for FY2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286406079.md"
description: "Alibaba Health Information Technology has declared a final ordinary cash dividend of RMB 0.0595 per share for FY2026, pending shareholder approval on 7 August 2026. The ex-dividend date is 12 August, with a record date of 13 August and payment scheduled for 2 September 2026. The company has appointed Tricor Investor Services Limited as its share registrar. The latest analyst rating for the stock (HK:0241) is a Sell with a price target of HK$4.60. Alibaba Health focuses on technology-enabled healthcare solutions in mainland China and other markets."
datetime: "2026-05-14T10:40:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286406079.md)
  - [en](https://longbridge.com/en/news/286406079.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286406079.md)
---

# Alibaba Health Declares Final Dividend for FY2026

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Alibaba Health Information Technology ( (HK:0241) ) has issued an announcement.

Alibaba Health Information Technology has declared a final ordinary cash dividend of RMB 0.0595 per share for the financial year ended 31 March 2026, with the Hong Kong dollar equivalent and exchange rate to be announced. The dividend is subject to shareholder approval on 7 August 2026, with the shares trading ex-dividend on 12 August, a record date of 13 August, and payment scheduled for 2 September 2026, signaling a return of cash to investors and underscoring the company’s commitment to shareholder returns.

The company has appointed Tricor Investor Services Limited in Hong Kong as its share registrar to handle entitlement and registration matters related to this distribution. No special withholding tax arrangements, warrants, or convertible securities are associated with this dividend, and the announcement also confirms the current composition of the board, providing governance transparency alongside the payout details.

The most recent analyst rating on (HK:0241) stock is a Sell with a HK$4.60 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.

**More about Alibaba Health Information Technology**

Alibaba Health Information Technology Limited is a Hong Kong-listed healthcare technology company operating in the broader health services and medical e-commerce space. It focuses on providing technology-enabled healthcare solutions and related services to consumers and medical stakeholders in mainland China and other relevant markets.

**Average Trading Volume:** 85,020,990

**Technical Sentiment Signal:** Strong Sell

**Current Market Cap:** HK$72.76B

### Related Stocks

- [00241.HK](https://longbridge.com/en/quote/00241.HK.md)

## Related News & Research

- [Nakamoto Reports First Quarter 2026 Results | NAKA Stock News](https://longbridge.com/en/news/286317239.md)
- [FRONTERA ANNOUNCES FIRST QUARTER 2026 RESULTS | FECCF Stock News](https://longbridge.com/en/news/286507909.md)
- [Distinct Healthcare Launches 2026 Share Award Scheme Funded by Existing Shares](https://longbridge.com/en/news/286330271.md)
- [Medicare costs rise in 2026 as surcharges hit high earners](https://longbridge.com/en/news/286025711.md)
- [Xtant Medical Reports First Quarter 2026 Financial Results | XTNT Stock News](https://longbridge.com/en/news/286247087.md)